# Oral Dosage Form New Animal Drugs; Clindamycin Capsules and Tablets
> **Food and Drug Administration** · Final rule. · Published 2004-06-09 · Effective 2004-06-09 · 69 FR 32272
## Document
- **Document number:** 04-12961
- **Category:** other
- **Sub-agency:** Food and Drug Administration
- **Federal Register citation:** 69 FR 32272
- **CFR reference:** 21 CFR 520
- **Publication date:** 2004-06-09
- **Effective date:** 2004-06-09
## Abstract

The Food and Drug Administration (FDA) is amending the animal drug regulations to reflect approval of two supplemental abbreviated new animal drug applications (ANADAs) filed by Phoenix Scientific, Inc. One supplemental ANADA provides for an expanded dose range and revised indications wording for the oral use of clindamycin hydrochloride capsules in dogs for the treatment of certain bacterial diseases. The other supplemental ANADA provides for use of a 300-milligram capsule size.

## Source
- [Federal Register document](https://www.federalregister.gov/documents/2004/06/09/04-12961/oral-dosage-form-new-animal-drugs-clindamycin-capsules-and-tablets)
---
*AI Analytics · CC0 1.0*